In this study, we showed, for the first time, that MUC5B can promote goblet cell differentiation and inflammation in a murine model of COPD model and that MUC5B exerts these effects by interfering with the STAT6-SPDEF pathway or the function of macrophages. Here, STAT6 is linked to chronic obstructive pulmonary disease.